Form 4 for ASTH Astrana Health, Inc.
Accepted 2024-11-20 00:00:00 ET · period of report 2024-11-19 · accession 0001104659-24-121026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-20 | 2024-11-19 | ASTH | Chiang John | Dir | M - OptEx | $18.41 | +1,515 | 17.4K | +10% | +$27.9K |
| D | 2024-11-20 | 2024-11-19 | ASTH | Chiang John | Dir | F - Tax | $40.93 | -681 | 16.7K | -4% | -$27.9K |
| D | 2024-11-20 | 2024-11-19 | ASTH | Chiang John | Dir | M - OptEx | $0.00 | -1,515 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-19 | M | A | 1,515 | $18.41 | 17,364 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-19 | F | D | 681 | $40.93 | 16,683 | D | — | — | (F2) Includes 4,750 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders. |
| 3 | Derivative | Stock Option (right to buy) | 2024-11-19 | M | D | 1,515 | $0.00 | 0 | D | $18.41 · — to 2024-11-25 | 1,515 Common Stock | (F1) These stock options were fully vested and exercisable. |